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Abstract 
Multidrug resistance were investigated in 75 Clostridium difficile clinical isolates collected during the period of first 
of June 2013 till the end of april 2014. These isolates show ( 100% ) resistance to Colistin, Nalidixic acid, 
Cefotaxime, gentamycin, and high resistance to Clindamycin(95%), Ciprofloxacin(88%) , and moderate resistance to 
Erythromycin (65%), Ampicillin (53%), while show good sensitive to chloramphenicol ( 80%), and among these 
antibiotics, Vancomycin and metronidazol was the most effective antibiotic against Cdifficile isolates with high 
sensitivity (100%) ,(95%) respectively. 
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Introduction 
Clostridium difficile has been traditionally regarded as a nosocomial human pathogen. 
In fact, several authors reported that this bacterium is an important cause of infectious diarrhea that usually 
develops in patients after hospitalization and antibiotic treatment. 
The symptoms of infection range from asymptomatic colonization to mild diarrhea and severe life 
threatening pseudomembranous colitis.( Kra et al.,2014).  
In the community setting, there is substantial variation in the risk of CDI associated with different 
antimicrobial classes. Avoidance of high-risk antibiotics (such as clindamycin, fluoroquinolones) in favor of 
lower-risk antibiotics (such as tetracyclines) may help reduce the incidence of CDI(Kevin et al.,2013; Daniel et 
al.,2015). 
C. difficile is an anaerobic, Gram-positive bacterium that has been implicated as the leading cause of 
antibiotic-associated diarrhea ,the pathogenic effects of C. difficile are mucosal damage to the colon that is 
caused by the production of toxin A (308 kDa) and/or toxin B (270 kDa)( Victor et al.,2014) . Metronidazole is 
currently the first-line treatment for mild to moderate C. difficile infections. Recent reports have identified 
treatment failure and relapse post metronidazole therapy, as well as reduced susceptible or metronidazole-
resistant C. difficile strains from clinical isolates(Chong et al.,2014). Antibiotic exposure was an important risk 
factor for community-associated infection , but the risk was different amongst different antibiotic classes. 
The risk was greatest with clindamycin followed by fluoroquinolones and cephalosporins, whereas 
tetracyclines were not associated with an increased risk (Abhishek et al.,2013; Daniel et al.,2015). This 
emphasizes the need for antimicrobial susceptibility testing of C. difficile and for a simple susceptibility testing 
method for the routine clinical microbiology laboratory. Disk diffusion is inexpensive and simple to perform and 
a few studies have evaluated disk diffusion for antimicrobial susceptibility testing of C. difficile(Huhulescu et 
al.,2011; Erikstrup et al.,2012).  
 
Material and Methods. 
Bacterial isolates and identification: 
Four hundred thirty stool samples were collected from Iraqi patient ,children and adults suffering from antibiotic 
associated diarrhea ,and apparently healthy children and adults as showing in table (1) .Stool samples were 
streaked on selective media( CCFA ) +7%horse blood as (George et al.,1979) ,incubation in anaerobic 
conditions at 37C0 for 48hrs ,and isolates were presumptively identified (Gram stain , and Malachite green for 
spore ) ,definitive identification was performed by Api20A kit (BioMerieux ,USA), and detection of two toxins 
A& B in stool samples by ELISA Kit (Premier toxin A&B from Meridian Bioscience ,USA), according to the 
manufacturer’s recommendations. Seventy five isolates positive for Clostridium difficile were selected for study .  
 
Antibiotic dick: Disk diffusion was performed with Oxoid disks (Oxoid, UK). 
Antimicrobial susceptibility testing 
Antimicrobial susceptibility testing to 11 antimicrobials(colistin, nalidixic acid, ,cefotaxime, clindamycin , 
gentamycin, ciprofloxacin, erythromycin, ampicillin, and chloramphenicol, vancomycin and metronidazol) was 
carried out for 75 isolates for C. difficile by the disk diffusion method on Muellere Hinton agar+  5% 
blood(HiMedia, India) (Ebrahim et al., ,2014) , according to Clinical and Laboratory Standards Institute (CLSI) 
guidelines (CLSI ,2011).The antimicrobial agents tested were chosen because of emergence of reduced 
susceptibility. 
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Results and Discussion. 
Seventy five C. difficile isolates were tested for antibiotic sensitivity. All isolates shown 100% resistant to each 
of Colistin, Nalidixic acid, ,Cefotaxime, Gentamycin. Also high resistance to Clindamycin , Ciprofloxacin was 
95% and 88% respectively. The moderate resistance show to Erythromycin 65%, Ampicillin 53%. 
Chloramphenicol has good sensitive 80% , while excellent sensitivity was showed to vancomycin and 
metronidazole 100% and 95% respectively. (table.1), figure(1). There is significant association as p˂ 0.01 
between C.difficile isolates and these antibiotics except Ampicillin 47% sensitive has not significant. 
This results coincides with pervious study shown 100% resistant to Colistin, Gentamycin,( Norakhoda 
et al.,2010) and 100% resistant to Cefotaxime, Clindamycin89% (Mehdi et al.,2013) and (Alexander et al., 
2007) shown 100% resistance to Clindamycin . Pervious study shown high resistance of C. difficile to 
Clindamycin, Gentamycin, Nalidixic acid, Ciprofloxacin, but in agreement with them that C.difficile high 
resistance to Erythromycin and Ampicillin ( Ebrahim et al.,2014). 
Our result agreement with (Mehdi et al.,2013) that shown moderate resistance to Erythromycin 57%, 
and with( Patrizia et al.,2011) that shown a good sensitive to Chloramphenicol, but in agreement about 
resistance to Clindamycin 48%, Erythromycin 48%. Previous studies (Norakhoda et al.,2010;Kang et al.,2012) 
shown moderate resistance to Clindamycin. 
The current results coincides with previous studies (Alexander et al., 2007;; Patrizia et al.,2011 ; Kang 
et al.,2012 ;; Ebrahim et al.,2014) they found all isolates100% were sensitive to Metronidazole and Vancomycin. 
Our resealts similar to previous studies in Iran(Norakhoda et al.,2010 )with high sensitivity to vancomycin 
(100%) and metronidazol(91%), and the same as ( Mehdi et al., 2013) that show high sensitive to Metronidazol 
(94%), and Vancomycin(92%). and with(Norakhoda et al.,2010 ;Patrizia et al.,2011) that shown a good sensitive 
to Chloramphenicol, 
Metronidazole is highly active against most strains of pathogenic C difficile with only rare reports of 
antibiotic resistance.( Johnson et al., 2000) . Increasing evidence suggests, that prolonged exposure to 
metronidazole can lead to resistance( Pelaez et al.,2008) and that susceptibility decreases over time(.Baines et 
al.,2008) For this reason, surveillance of antibiotic resistance in C difficile is ongoing and resistance could limit 
the use of this antibiotic in the future. Metronidazole is generally recommended as the first-line treatment of C 
difficile. It induces microbial cell death by DNA disruption and subsequent inhibition of nucleic acid synthesis. 
Metronidazole is most effective in anaerobic sites such as the human colonic lumen. In addition to its 
antimicrobial properties, metronidazole also appears to have anti-inflammatory, antioxidant, and 
immunomodulatory effects (Baines et al,2008) .Vancomycin inhibits bacterial cell wall synthesis has broad 
activity against gram-positive bacteria, but it essentially has no effect on gram-negative bacteria or fungi. 
Vancomycin is highly active against all strains of pathogenic C difficile, and resistance has been reported in only 
a single study. Vancomycin is recommended as first-line therapy in pregnant women, in children younger than 
10 years of age, and for severe infections. Metronidazole and vancomycin still seem to be most effective drugs 
for treatment CDI.( Bourgault et al.,2006 ; Moellering et al.,2006; Zar FA et al,2007). 
 
Table 1. Distribution of sample study according to antibiotic sensitive  
 
Antibiotic µg\disc 
Sensitive Intermediate  Resistance Chi-
square- χ2 No.  (%) No.  (%) No.  (%) 
Vancomycin, 30 75 100 0 0 0 0.00 14.39 ** 
Metronidazole,5 71 95.0 0 0 4 5.00 13.70 ** 
Clindamycin,10 4 5.00 0 0 71 95.0 13.74 ** 
Gentamycin,10  0 0.00 0 0 75 100 14.50 ** 
Ampicillin,25  35 47.0 0 0 40 53.0 1.09 NS 
Chloramphenicol,10 60 80.0 0 0 15 20.00 10.66 ** 
Erythromycin,15 26 35.0 0 0 49 65.00 9.27 ** 
Colistin ,10 0 0.00 0 0 75 100 14.50 ** 
Nalidixicacid,30  0 0.00 0 0 75 100 14.50 ** 
Ciprofloxacin,10 9 12.0 0 0 66 88.00 12.94 ** 
Cefotaxime,10  0 0.00 0 0 75 100 14.50 ** 
Chi-square- χ2 ---- 16.38 ** --- 0.00 NS ---- 16.38 ** ---- 
  ** (P<0.01), NS: Non-significant. 
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